Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARL5A pseudogene 1 (ARL5AP1) is a non-protein-coding genomic element classified as a pseudogene related to the ARL5A gene. It does not produce functional protein and is not implicated in therapeutic mechanisms, molecular interactions, or disease processes as a direct target. Its primary significance is in genomic annotation, and it should not be confused with ARL5A, which is an ARF family GTPase protein involved in nuclear dynamics, signaling, and disease[1][7]. If structured, ARL5AP1 should not be annotated as a drug target, nor associated with functional protein attributes. For drug and disease relevance, refer instead to the protein-coding ARL5A gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARL5A pseudogene 1 (ARL5AP1).